• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Practical recommendations for kidney transplantation in the COVID-19 pandemic

    2020-12-29 13:32:57AshrafImamKerenTzukertHadarMerhavRihamImamSamirAbuGazalaRoyAbelMichalDranitzkiElhalelAbedKhalaileh
    World Journal of Transplantation 2020年9期

    Ashraf Imam, Keren Tzukert, Hadar Merhav, Riham Imam, Samir Abu-Gazala,Roy Abel, Michal Dranitzki Elhalel, Abed Khalaileh

    Ashraf Imam, Hadar Merhav, Riham Imam, Samir Abu-Gazala, Abed Khalaileh, Transplantation Unit, Department of Surgery, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel

    Keren Tzukert, Roy Abel, Michal Dranitzki Elhalel, Department of Nephrology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel

    Abstract Kidney transplantation at the time of a global viral pandemic has become challenging in many aspects. Firstly, we must reassess deceased donor safety (for the recipient) especially in communities with a relatively high incidence of coronavirus disease 19 (COVID-19). With respect to elective live donors, if one decides to do them at all, similar considerations must be made that may impose undue hardship on the donor. Recipient selection is also problematic since there is clear evidence of a much higher morbidity and mortality from COVID-19 for patients older than 60 and those with comorbidities such as hypertension, diabetes, obesity and lung disease. Unfortunately, many, if not most of dialysis patients fit that mold. We may and indeed must reassess our allocation policies, but this must be done based on data rather than conjecture. Follow-up routines must be re-engineered to minimize patient travel and exposure. Reliance on technology and telemedicine is paramount. Making this technology available to patients is extremely important. Modifying or changing immunosuppression protocols is controversial and not based on clinical studies. Nevertheless, we should reassess the need for induction therapy across the board for ordinary patients and the more liberal use of mammalian target of rapamycin inhibitors in transplant patients with proven infection.

    Key Words: COVID-19; Kidney transplantation; Organ donation; Coronavirus; SARSCoV2

    INTRODUCTION

    Kidney transplantation (KT) is the treatment of choice for end-stage kidney disease[1]. The progress in immunosuppression along with the advances in surgical techniques has led to an improvement in transplantation outcomes. However, the increased risk of infection in immunocompromised patients can negatively affect the results of transplantation. The appearance of the new coronavirus disease 2019 (COVID-19), which is highly infectious and carries a high mortality risk, presents significant challenges to transplantation in general, to KT in particular and to living donor KT specifically.

    COVID-19 is caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV2)[2]. COVID-19 was confirmed following several severe cases of pneumonia in the city of Wuhan in China in December 2019[3], and shortly thereafter, this disease spread worldwide[4]affecting more than 1.5 million people with more than 110 thousand deaths[5]. In Israel, the first diagnosed case of COVID-19 was announced on February 21, 2020. Since then, more than 11000 cases have been confirmed of which 110 died[6]. As reported elsewhere, COVID-19-related mortality is far more prevalent in older patients and those with comorbidities[7].

    During the SARS epidemic in 2003 and the Middle East respiratory syndrome (MERS) in 2018, there was no increased mortality among immunocompromised patients[8,9]. Conversely, in the current COVID-19 pandemic, several reports have demonstrated the severity of this disease among immunocompromised transplanted patients[10,11].

    Under the current circumstances, there are clear obstacles and challenges that almost all transplant centers in the world encounter due to the lack of evidence-based medicine regarding kidney transplant management in this setting. In this report, we highlight our local measures and guidelines that were adopted by the KT unit at Hadassah – Hebrew University Medical Center in Jerusalem, Israel.

    DECEASED DONORS

    We expected the number of organs from deceased donors to decrease during the pandemic, as a result of the extreme load on the intensive care units causing care to be diverted from brain dead potential donors. Also, at times of societal stress, the tendency to donate organs goes down and lastly due to the social distancing there are far less road accidents and brain injuries. Surprisingly, our center was only minimally affected regarding deceased donors during this period.

    The risk of transmission of COVID-19 by a deceased donor is not yet known, but we believe that there is a possibility of viral transmission, since it was reported that there is a 15% chance of isolating the virus from blood[12]. Moreover, some pathological changes were reported in organs other than the lungs in COVID-19 patients[13].

    In order to minimize the previously mentioned potential hazards, whether they are from the donor, the recipient or the team, we adopted the recommendations of the National Transplantation Steering Committee for consideration of a potential deceased kidney donor. These criteria include: (1) The donor must have a negative nasopharyngeal swab for COVID-19; (2) The donor should have no history of traveling abroad in the last 14 days and no exposure to a proven COVID-19 patient; (3) Every potential donor with diagnosed pneumonia should test negative for COVID-19, if no test can be performed the donor is rejected; (4) A donor that was treated by a medical team that took care of proven COVID-19 patients should be rejected; and (5) In the case of a donor with cardiac death (DCD), if there is insufficient time to gather all this information, the donor should be rejected. By accumulating knowledge on COVID-19 disease, we believe the following additional factors should be considered: (1) The presence of upper respiratory symptoms or fever; (2) Lymphopenia; (3) Chest computed tomography (CT) scan with findings that can be attributed to COVID-19 infection; and (4) High suspicion of COVID-19 infection, based on epidemiologic and clinical signs, even if COVID-19 polymerase chain reaction (PCR) is negative. We also apply the same criteria for liver donors.

    The importance of performing a chest CT scan and considering lymphopenia for every potential donor stems from the report published by Guanet al[14]who demonstrated that in a large cohort of 1099 COVID-19 patients, 96% of the patients had specific abnormal findings in the lungs, and 82.1% had lymphopenia.

    Regarding the 5threcommendation of the steering committee for a DCD donor, we recommend that the technique of machine perfusion should be utilized. This can provide a relatively safe environment for the kidneys and even enhance their performance while allowing additional time for missing data to be acquired. The application of these strict criteria on potential deceased kidney donors should decrease the risk of infection for both the transplant team and future recipients.

    LIVING DONORS

    Transplantation from living donors brings additional considerations. These are elective, pre-scheduled carefully planned transplantations[15]. Thus, stringent safety criteria must be implemented in order to protect the donor, the recipient and the team.

    We believe that donors must undergo a period of 14 d isolation prior to transplantation. This may prove to be an undue and indeed unbearable burden for some donors and is to be explained at length during medical and psychosocial evaluation. Of note, PCR tests still show significant percentages of false negative results, and antibody detection assays are not yet commonly available.

    The recent outbreak resulted in the Ministry of Health and transplantation centers temporarily withholding all living-related transplantation activities. This will eventually lead to an increased number of patients on dialysis treatment, with its prognostic and financial implications.

    KIDNEY TRANSPLANT RECIPIENTS

    In Israel, there are more than 857 patients on the waiting list. All of which are treated by dialysis, nevertheless, this number does not include patients who may need preemptive kidney transplant. In 2019, a total of 411 KT were performed in Israel, 248 from living donors and 163 from deceased donors[16].

    In order to minimize the damage from the decreased number of donations, every effort should be made to stratify the patients who may be able to benefit from a kidney transplant in this pandemic era.

    In Israel, we have implemented an old for old allocation policy for many years with great success. However, in these times, when it is clear that COVID-19 infection severity and mortality increase with age and comorbidities[7,17]we may need to reconsider this policy. Our present approach is that older recipients (> 65 years) should be informed of their inherent greater risk and if they decline the offer it should be rerouted to a younger patient. Although there is presently no data to make any projection or firm recommendation, we believe that due to the pandemic a reassessment of allocation policies in order to maximize safety and reduce mortality, morbidity and graft loss may be required.

    Finally, according to the recommendations that were published on March 20, 2020 by the European Dialysis Working Group of ERA-EDTA, dialysis patients should be instructed to stay away from crowds whenever possible, to use individual means of transportation, to use protective measures in order to conserve their hygiene , and even to avoid personal contact with family members[18]. We suggest that these recommendations should be applied to kidney transplant recipients during and after hospitalization.

    POST-OPERATIVE FOLLOW-UP

    The clinical course following KT is fraught with complications in the best of cases. In order to minimize this, patients are advised to adhere to a strict follow-up routine. COVID-19 may expose these patients to added hazards when traveling and visiting medical clinics. As a result, we suggest tailoring an individual follow-up strategy that balances the risks with the needed intensity of visits for each patient. The plethora of technology devices and applications allowing effective telemedicine should be used as much as possible. However, patients who lack smart phones or computers with internet access may present a problem. In Israel this is almost universally due to religious prohibition and can be dealt with in an ad hoc manner. In places where economic considerations prevent patients from accessing technology, reach-out should be made to insurers, providers and charitable institutions to step into the gap. Telemedicine will assume an important future role in the care of these patients. Particular emphasis should be placed on strict adherence to the government's instructions regarding social isolation, hygiene habits and awareness of the signs and symptoms related to COVID-19. This means that patients arriving at clinics must have N95 masks and wear gloves. This personal protective equipment should be prescribed and delivered to transplant patients.

    IMMUNOSUPPRESSION

    Intuitively, one would tend to decrease immunosuppression in the face of a viral pandemic. We do not have any information as to whether that will benefit patients and the consequences are almost surely increased rates of rejection, increased immunosuppression, infection and graft loss. Thymoglobulin, a T cell depleting agent, is routinely used as an induction treatment. It has been linked to an increased rate of viral infections such as CMV, HSV and BK and to viral-related complicationse.g., posttransplant lymphoproliferative disorder[19]. Thus, it makes sense to speculate that it will increase the rate and the severity of COVID-19 infections. Its advantage is that it decreases the rate of rejection and allows the use of lower CNI levels. If the recipient is of higher immunological risk, the importance of thymoglobulin induction rises. Therefore, should we avoid thymoglobulin and move to non-depleting regimens,e.g., Basiliximab (CD25R antagonist) or avoid induction at all? This will increase the risk of acute rejection, and if rejection occurs this could result in a whole anti-rejection treatment protocol accumulating to a much larger dose of immunosuppression. The issue of induction therapy for all needs to be examined and perhaps there is logic in using induction for higher immunological risk recipients. Nevertheless, at this time, due to lack of evidence-based reports, we believe institutions should continue their induction practices as before.

    Corticosteroids have a major role in all anti-rejection protocols. In our institution, high dose methylprednisolone is given with induction with rapid tapering off down to 40 mg/day on day 6. Routinely, we do not use steroid-avoidance or steroid withdrawal protocols. Should one move to steroid-avoidance protocols now? No decrease in CMV infection rate was found when steroid avoidance or withdrawal protocols were compared to steroid maintenance protocols[20], and data regarding BK nephritis rates are conflicting. When investigating the previous, SARS-COVID experience, the Chinese reported advantageous outcomes when combining high dose steroids with hydroxychloroquine[21]and recently, a favorable outcome was suggested when steroids were used in the context of a cytokine storm[17,22]. However, studies in animal models indicated that long-term use of steroids facilitates viral replication[23]. According to existing (or non-existing evidence-based data), we believe that we should continue using the current steroid protocol that we practice and are familiar with, as no clear evidence proves that avoiding steroids would be of any benefit.

    Anti-metabolites, mainly mycophenolate, are used in most maintenance protocols, depleting and interfering with both B and T lymphocytes functions. MPA was shown to inhibit viral replication of 4 different coronaviruses (not including COVID-19) in cell culture[24]. Unfortunately, animal models indicated that MPA worsened disease activity in both common marmosets (significantly higher mortality)[25]and Balb/c mice[26]. MPA together with interferon-b was associated with survival in one clinical report of MER-CoV patients. However, this was significant only in univariate analysis and the greater predictor of survival was disease severity at presentation[27]. Taken together, and in agreement with our common practice during viral infections such as CMV, EBV or HSV, we tend to lower mycophenolate dose and even to hold it. In the case of the few transplant patients we treated for COVID19 infection, who presented with leukopenia, we stopped mycophenolate. We plan to re-start mycophenolate when 2 consecutive COVID 19 PCR tests are negative.

    The calcineurin inhibitors, cyclosporine and tacrolimus are the mainstay of immunosuppression regimens for solid organ transplantation, affecting T cell activation and function. Although there is no doubt regarding their efficacy, calcineurin inhibitors were linked to an increased rate of viral infections. Mammalian target of rapamycin (mTOR) inhibitors were suggested to be beneficial regarding viral infections (refs for BK, HPV viral verrucae). Should we convert the treatment protocol from CNIs to de-novo mTOR inhibitors? Should we use low dose CNI protocols together with low dose mTOR inhibitors? FK binding protein (FKBP) binds the coronavirus non-structural protein (NSP-1), thus explaining the mode of action of Tacrolimus inhibition of human coronavirus replication in cell culture[28]. However, no data are available on CNI effectiveness in inhibiting disease progression in animal models or humans.

    MTOR inhibitors were shown to inhibit MERS-CoV replicationin vitro[29]Another work based on network drug repurposing suggested Sirolimus as a potential treatment for coronavirus infection[30]. Taken together, it is still unclear if CNI should be avoided or minimized, but in low immunological risk patients, mTOR inhibitorsbased protocols along with low dose CNI are a reasonable possibility.

    In summary, choosing immunosuppressive protocols during the COVID-19 pandemic is challenging. This is true for induction and treatment for newly transplanted patients as well as for maintenance treatment and for infected transplanted patients. Literature is scarce and mostly inconclusive. One should probably use well practiced protocols, avoid over-immunosuppression as much as possible, and minimize it in stable patients. Infected patients should probably be evaluated for severity of symptoms and signs, and if mild, holding the antimetabolites is acceptable. If moderate or severe, it is possible to hold CNIs, but continue, or even increase the steroids dose.

    Contrary to the logic in decreasing immunosuppression during a pandemic, it is important to remember, that at these times ambulatory patients are more difficult to follow. Patients tend to refrain from arriving at the hospital for routine tests, even to outpatient clinics, and community clinics are overloaded. Downgrading the levels of immunosuppression will demand a very tight follow-up protocol that will enable detection of rejections at the earliest time.

    MEDICAL STAFF SAFETY

    The novel coronavirus has been threatening not only the lives of medical professionals, but also their mental health. This outbreak has caused enormous distress in many health workers who particularly deal with coronavirus patients. This is mainly explained by the various stressful situations including work overload, isolation and relentless fear of infecting patients and family and shortage of medical equipment in some cases[31,32]. In addition to this, the transplantation team is primarily exposed to distress and anxiety due to their stressful work, and this makes the pandemic even more severe. Moreover, it was reported that a number of medical health providers had committed suicide during this pandemic. These facts have caused a serious burden on health systems worldwide.

    CONCLUSION

    Measurements have been adopted by some governments including creating a telephone line for psychiatric consultations and mental health support to fight depression, suicidal attempts and other psychiatric issues.

    午夜福利欧美成人| 99久久综合精品五月天人人| 国产av精品麻豆| 岛国视频午夜一区免费看| 婷婷精品国产亚洲av在线| 国产乱人伦免费视频| 成人精品一区二区免费| 欧美成人免费av一区二区三区| av超薄肉色丝袜交足视频| 亚洲熟妇中文字幕五十中出 | 国产午夜精品久久久久久| 精品人妻1区二区| 丰满饥渴人妻一区二区三| 岛国在线观看网站| 色综合婷婷激情| 午夜免费鲁丝| 夫妻午夜视频| 人人澡人人妻人| 久久热在线av| 中文欧美无线码| 久久久久久久午夜电影 | 极品人妻少妇av视频| 午夜免费激情av| 嫩草影院精品99| 他把我摸到了高潮在线观看| 午夜影院日韩av| 亚洲熟女毛片儿| 亚洲色图av天堂| 欧美日韩瑟瑟在线播放| 91在线观看av| 淫妇啪啪啪对白视频| 男女高潮啪啪啪动态图| 中出人妻视频一区二区| 欧美色视频一区免费| 午夜免费激情av| 满18在线观看网站| 欧美日韩乱码在线| 一个人免费在线观看的高清视频| 国产欧美日韩一区二区三| avwww免费| 亚洲国产精品999在线| 国产欧美日韩一区二区三区在线| 国产视频一区二区在线看| www日本在线高清视频| 亚洲色图综合在线观看| 国产精品 欧美亚洲| 很黄的视频免费| 亚洲五月婷婷丁香| 十八禁网站免费在线| 国产野战对白在线观看| 水蜜桃什么品种好| 精品卡一卡二卡四卡免费| 婷婷丁香在线五月| 欧美日韩福利视频一区二区| 国产精华一区二区三区| 男女下面插进去视频免费观看| 成年人免费黄色播放视频| 午夜免费观看网址| 国产精品99久久99久久久不卡| xxxhd国产人妻xxx| 国产av一区在线观看免费| 自拍欧美九色日韩亚洲蝌蚪91| 国产精品美女特级片免费视频播放器 | 午夜免费观看网址| 久久狼人影院| 精品久久久久久,| 美女大奶头视频| 黄色 视频免费看| 欧美日韩黄片免| 中文亚洲av片在线观看爽| 欧美精品啪啪一区二区三区| xxxhd国产人妻xxx| 黄片播放在线免费| 久久国产精品人妻蜜桃| 日韩精品免费视频一区二区三区| 午夜91福利影院| 一级毛片精品| 久久久久国产一级毛片高清牌| 亚洲免费av在线视频| 免费不卡黄色视频| 黄色片一级片一级黄色片| 男人操女人黄网站| 18禁美女被吸乳视频| videosex国产| 国产精品一区二区三区四区久久 | 亚洲中文av在线| 亚洲av电影在线进入| 亚洲久久久国产精品| 精品一品国产午夜福利视频| 新久久久久国产一级毛片| 老司机靠b影院| 精品电影一区二区在线| 又紧又爽又黄一区二区| 久久精品亚洲熟妇少妇任你| 一本大道久久a久久精品| 亚洲国产欧美网| 免费在线观看日本一区| 国产精品一区二区免费欧美| 欧美另类亚洲清纯唯美| 免费久久久久久久精品成人欧美视频| 91老司机精品| 人人澡人人妻人| 久久国产亚洲av麻豆专区| 淫妇啪啪啪对白视频| 脱女人内裤的视频| 国产成人免费无遮挡视频| 精品福利观看| 亚洲精品成人av观看孕妇| 妹子高潮喷水视频| 新久久久久国产一级毛片| 亚洲伊人色综图| 91字幕亚洲| 亚洲成人久久性| 久久久久久免费高清国产稀缺| 久热爱精品视频在线9| 热99国产精品久久久久久7| 香蕉久久夜色| 亚洲专区字幕在线| 精品卡一卡二卡四卡免费| 日日夜夜操网爽| 我的亚洲天堂| 国产成人av激情在线播放| 精品第一国产精品| 天堂影院成人在线观看| 成人18禁在线播放| 中文字幕色久视频| 国产区一区二久久| 一级作爱视频免费观看| tocl精华| 成年人黄色毛片网站| 视频在线观看一区二区三区| 免费搜索国产男女视频| 99精国产麻豆久久婷婷| 19禁男女啪啪无遮挡网站| 国产黄a三级三级三级人| 亚洲精品美女久久久久99蜜臀| 久久中文看片网| 日韩精品免费视频一区二区三区| 巨乳人妻的诱惑在线观看| 一a级毛片在线观看| 99re在线观看精品视频| 亚洲美女黄片视频| 色在线成人网| 欧美av亚洲av综合av国产av| 久久精品国产亚洲av香蕉五月| av欧美777| 男人舔女人下体高潮全视频| 欧美老熟妇乱子伦牲交| 国产精品日韩av在线免费观看 | 999精品在线视频| 亚洲成人免费av在线播放| 久久人人97超碰香蕉20202| 日本五十路高清| 国产不卡一卡二| 国产精品久久久人人做人人爽| 欧美黄色片欧美黄色片| 一二三四社区在线视频社区8| 久久中文字幕人妻熟女| 久久人妻熟女aⅴ| 亚洲一区二区三区欧美精品| 午夜福利在线观看吧| 亚洲五月婷婷丁香| 久久精品亚洲av国产电影网| 久久这里只有精品19| 人妻久久中文字幕网| 亚洲欧洲精品一区二区精品久久久| 成人18禁在线播放| 99国产精品99久久久久| 一边摸一边抽搐一进一出视频| 亚洲成人免费电影在线观看| 一区二区日韩欧美中文字幕| 国产xxxxx性猛交| 欧美黄色片欧美黄色片| 国产成人精品在线电影| 狠狠狠狠99中文字幕| 99在线视频只有这里精品首页| 久久午夜亚洲精品久久| 在线观看日韩欧美| av天堂久久9| 中文字幕高清在线视频| 成人永久免费在线观看视频| 757午夜福利合集在线观看| 精品国产超薄肉色丝袜足j| 精品久久久久久,| avwww免费| 国产91精品成人一区二区三区| 一二三四社区在线视频社区8| 久久久精品欧美日韩精品| 性色av乱码一区二区三区2| 亚洲黑人精品在线| 一区二区三区精品91| 别揉我奶头~嗯~啊~动态视频| 国产麻豆69| 97超级碰碰碰精品色视频在线观看| 久久草成人影院| 国产区一区二久久| 夫妻午夜视频| 亚洲自偷自拍图片 自拍| 精品一区二区三区视频在线观看免费 | 久久人人爽av亚洲精品天堂| 午夜日韩欧美国产| 亚洲色图av天堂| 国产99白浆流出| 自线自在国产av| 波多野结衣av一区二区av| 午夜福利,免费看| 男女之事视频高清在线观看| av网站免费在线观看视频| 欧美精品一区二区免费开放| 欧美另类亚洲清纯唯美| 色婷婷久久久亚洲欧美| 国产三级在线视频| 深夜精品福利| 成在线人永久免费视频| 亚洲五月天丁香| 亚洲人成伊人成综合网2020| 夫妻午夜视频| 精品福利观看| 国产野战对白在线观看| 91精品三级在线观看| 亚洲狠狠婷婷综合久久图片| 夜夜爽天天搞| 久久久国产成人免费| 国产区一区二久久| 欧美大码av| 亚洲av成人一区二区三| 国产乱人伦免费视频| 亚洲专区中文字幕在线| 波多野结衣av一区二区av| 亚洲激情在线av| 色综合站精品国产| 啪啪无遮挡十八禁网站| 久久久国产成人免费| 久久草成人影院| 精品一区二区三区av网在线观看| 国产亚洲精品一区二区www| 侵犯人妻中文字幕一二三四区| 三上悠亚av全集在线观看| 亚洲国产精品sss在线观看 | 亚洲精品美女久久av网站| 久久中文字幕人妻熟女| 中亚洲国语对白在线视频| 成人黄色视频免费在线看| 精品久久蜜臀av无| 高潮久久久久久久久久久不卡| 欧美乱码精品一区二区三区| 黄色成人免费大全| 日韩欧美国产一区二区入口| 国产高清激情床上av| 女性生殖器流出的白浆| 老鸭窝网址在线观看| 久久久精品国产亚洲av高清涩受| 欧洲精品卡2卡3卡4卡5卡区| 日日爽夜夜爽网站| 老司机在亚洲福利影院| 女人被躁到高潮嗷嗷叫费观| 国产不卡一卡二| 亚洲精品国产精品久久久不卡| 在线看a的网站| 午夜精品久久久久久毛片777| 可以在线观看毛片的网站| 成人特级黄色片久久久久久久| 一级a爱片免费观看的视频| 琪琪午夜伦伦电影理论片6080| 在线观看免费日韩欧美大片| 欧美丝袜亚洲另类 | 日韩免费高清中文字幕av| 两性夫妻黄色片| 国产精品一区二区在线不卡| 欧美日韩精品网址| 久久久国产欧美日韩av| 人人妻人人爽人人添夜夜欢视频| 免费女性裸体啪啪无遮挡网站| 老司机午夜十八禁免费视频| 色综合婷婷激情| 麻豆久久精品国产亚洲av | 欧美人与性动交α欧美精品济南到| 成年女人毛片免费观看观看9| 亚洲一区二区三区不卡视频| 波多野结衣av一区二区av| 欧美成人性av电影在线观看| 亚洲成国产人片在线观看| 亚洲中文日韩欧美视频| 中文亚洲av片在线观看爽| 欧美在线黄色| 女生性感内裤真人,穿戴方法视频| 色精品久久人妻99蜜桃| 日韩欧美在线二视频| 黄网站色视频无遮挡免费观看| 宅男免费午夜| 日韩欧美免费精品| 久9热在线精品视频| 亚洲精品国产色婷婷电影| 高清欧美精品videossex| 大型黄色视频在线免费观看| 久久精品国产清高在天天线| 18禁美女被吸乳视频| 无人区码免费观看不卡| 最新美女视频免费是黄的| 色老头精品视频在线观看| 亚洲全国av大片| 久久精品国产清高在天天线| 男女之事视频高清在线观看| 午夜老司机福利片| 亚洲欧美日韩高清在线视频| 国产精品98久久久久久宅男小说| 亚洲自拍偷在线| 久久久国产精品麻豆| 一区二区三区精品91| 国产精品久久电影中文字幕| 91在线观看av| 国产精品综合久久久久久久免费 | 女人爽到高潮嗷嗷叫在线视频| 不卡一级毛片| 亚洲激情在线av| 日韩av在线大香蕉| 亚洲免费av在线视频| 精品高清国产在线一区| 成人av一区二区三区在线看| 1024香蕉在线观看| a级毛片在线看网站| 成熟少妇高潮喷水视频| 亚洲欧美一区二区三区久久| 老熟妇仑乱视频hdxx| 亚洲成av片中文字幕在线观看| 在线观看免费日韩欧美大片| 中文字幕最新亚洲高清| 欧美精品亚洲一区二区| 一区福利在线观看| 久久人妻熟女aⅴ| 久久久久久亚洲精品国产蜜桃av| 在线国产一区二区在线| 韩国精品一区二区三区| 久久久久久久午夜电影 | 亚洲中文字幕日韩| 美女高潮喷水抽搐中文字幕| 国产精品偷伦视频观看了| 丰满迷人的少妇在线观看| 国产精品免费视频内射| 日韩精品免费视频一区二区三区| 51午夜福利影视在线观看| 久久精品国产99精品国产亚洲性色 | 一区二区日韩欧美中文字幕| 国产成人精品久久二区二区91| 亚洲国产中文字幕在线视频| 国产精品1区2区在线观看.| 在线观看免费视频网站a站| 久久久久久久久久久久大奶| 欧美大码av| 丝袜在线中文字幕| 久久久久久久午夜电影 | 每晚都被弄得嗷嗷叫到高潮| 女生性感内裤真人,穿戴方法视频| 精品国产一区二区久久| 91九色精品人成在线观看| 伊人久久大香线蕉亚洲五| 免费高清在线观看日韩| 少妇的丰满在线观看| 欧美激情久久久久久爽电影 | 国产一区在线观看成人免费| 交换朋友夫妻互换小说| 亚洲av日韩精品久久久久久密| 视频在线观看一区二区三区| 国产成人一区二区三区免费视频网站| 国产亚洲精品综合一区在线观看 | 欧美在线黄色| 大香蕉久久成人网| 人人澡人人妻人| 丝袜在线中文字幕| 亚洲精品粉嫩美女一区| 制服诱惑二区| 99精品在免费线老司机午夜| 精品电影一区二区在线| 天天添夜夜摸| 两人在一起打扑克的视频| 亚洲va日本ⅴa欧美va伊人久久| 在线视频色国产色| 亚洲九九香蕉| 久久久国产成人精品二区 | 久久久久久大精品| 最新在线观看一区二区三区| 欧美精品啪啪一区二区三区| 99re在线观看精品视频| 午夜福利在线观看吧| 两个人看的免费小视频| 12—13女人毛片做爰片一| 国产欧美日韩精品亚洲av| 极品人妻少妇av视频| 中文字幕高清在线视频| 亚洲精品在线观看二区| 叶爱在线成人免费视频播放| 欧美另类亚洲清纯唯美| 亚洲精品在线美女| 99在线人妻在线中文字幕| 国产色视频综合| 免费在线观看日本一区| www.自偷自拍.com| av在线天堂中文字幕 | 咕卡用的链子| 亚洲第一av免费看| 人成视频在线观看免费观看| 50天的宝宝边吃奶边哭怎么回事| 国产高清视频在线播放一区| 亚洲久久久国产精品| 一进一出抽搐动态| 91九色精品人成在线观看| 午夜福利欧美成人| a在线观看视频网站| 男男h啪啪无遮挡| 午夜福利一区二区在线看| 亚洲欧美激情综合另类| 中文亚洲av片在线观看爽| 国产一区二区在线av高清观看| 国产区一区二久久| 国产乱人伦免费视频| 欧美老熟妇乱子伦牲交| av福利片在线| 在线十欧美十亚洲十日本专区| 精品国产美女av久久久久小说| 香蕉国产在线看| 亚洲av成人一区二区三| 久久狼人影院| 一区在线观看完整版| 老司机亚洲免费影院| 国产精品免费一区二区三区在线| 亚洲免费av在线视频| a级毛片黄视频| 深夜精品福利| 欧美日韩一级在线毛片| 韩国av一区二区三区四区| 亚洲国产精品sss在线观看 | 精品一区二区三区四区五区乱码| 欧美国产精品va在线观看不卡| 宅男免费午夜| 别揉我奶头~嗯~啊~动态视频| 9191精品国产免费久久| 男人舔女人下体高潮全视频| 欧美精品一区二区免费开放| 美国免费a级毛片| 亚洲成人国产一区在线观看| 欧美黄色淫秽网站| 亚洲中文字幕日韩| 国产精品爽爽va在线观看网站 | 中文字幕精品免费在线观看视频| 久久精品国产亚洲av香蕉五月| 欧美色视频一区免费| 国产成+人综合+亚洲专区| 欧美黑人精品巨大| 日韩有码中文字幕| www日本在线高清视频| 美女高潮喷水抽搐中文字幕| aaaaa片日本免费| 国产精品98久久久久久宅男小说| 亚洲精品粉嫩美女一区| 丰满迷人的少妇在线观看| 国产亚洲精品第一综合不卡| 18美女黄网站色大片免费观看| 欧美人与性动交α欧美精品济南到| 多毛熟女@视频| 大型黄色视频在线免费观看| 在线看a的网站| 精品国产乱子伦一区二区三区| 国产亚洲精品第一综合不卡| 丝袜人妻中文字幕| 亚洲国产欧美网| 国产av一区二区精品久久| 国产极品粉嫩免费观看在线| 又黄又爽又免费观看的视频| 在线天堂中文资源库| 精品日产1卡2卡| 亚洲精品国产区一区二| 中文字幕另类日韩欧美亚洲嫩草| 国产日韩一区二区三区精品不卡| 亚洲精品在线观看二区| 日韩大码丰满熟妇| 亚洲午夜理论影院| 宅男免费午夜| 在线av久久热| 妹子高潮喷水视频| 亚洲欧美一区二区三区黑人| 夜夜躁狠狠躁天天躁| 丁香欧美五月| 香蕉国产在线看| 色婷婷久久久亚洲欧美| 亚洲久久久国产精品| 国产精品1区2区在线观看.| 国产成人精品在线电影| 亚洲在线自拍视频| 99re在线观看精品视频| 波多野结衣一区麻豆| 亚洲色图av天堂| 国产有黄有色有爽视频| 国产成人av激情在线播放| 男人舔女人下体高潮全视频| 精品一区二区三区四区五区乱码| 精品国产超薄肉色丝袜足j| 久久精品国产亚洲av高清一级| 黄色a级毛片大全视频| 欧美黑人精品巨大| 久久草成人影院| 最好的美女福利视频网| 99在线视频只有这里精品首页| 九色亚洲精品在线播放| 久久精品国产亚洲av高清一级| 一级毛片高清免费大全| 另类亚洲欧美激情| 女人被狂操c到高潮| 老司机靠b影院| 黄片大片在线免费观看| 欧美精品啪啪一区二区三区| 五月开心婷婷网| 天堂影院成人在线观看| 美女大奶头视频| 日韩有码中文字幕| 日本黄色视频三级网站网址| 交换朋友夫妻互换小说| 99久久99久久久精品蜜桃| 午夜福利,免费看| www.精华液| 村上凉子中文字幕在线| 黄片大片在线免费观看| 国产精品国产高清国产av| 成在线人永久免费视频| 中文字幕av电影在线播放| 国产成年人精品一区二区 | 妹子高潮喷水视频| 国产精品 国内视频| 成年版毛片免费区| 亚洲欧美一区二区三区黑人| 欧美乱色亚洲激情| 国产精品一区二区三区四区久久 | 色老头精品视频在线观看| 日本免费a在线| 日韩国内少妇激情av| 亚洲av第一区精品v没综合| 91在线观看av| 成人亚洲精品一区在线观看| 黄色怎么调成土黄色| 久久中文看片网| 免费av中文字幕在线| 精品国产一区二区三区四区第35| 国产成人一区二区三区免费视频网站| 欧美日韩黄片免| 亚洲一区二区三区欧美精品| 女性被躁到高潮视频| 亚洲九九香蕉| 啦啦啦在线免费观看视频4| 美女高潮喷水抽搐中文字幕| 高清在线国产一区| 宅男免费午夜| 淫妇啪啪啪对白视频| 在线免费观看的www视频| 久久久久久久久免费视频了| 丰满的人妻完整版| 老司机福利观看| 日韩成人在线观看一区二区三区| 日本wwww免费看| 精品电影一区二区在线| 亚洲色图 男人天堂 中文字幕| 国产精品亚洲一级av第二区| 国产精品 国内视频| 757午夜福利合集在线观看| 香蕉丝袜av| 精品国产国语对白av| 国产三级黄色录像| 一级毛片女人18水好多| 亚洲成av片中文字幕在线观看| 久久人人爽av亚洲精品天堂| 午夜免费观看网址| 国产精品永久免费网站| 在线观看免费视频网站a站| 久久久国产一区二区| 国产在线观看jvid| 国产精品亚洲av一区麻豆| 日韩欧美国产一区二区入口| 在线观看免费午夜福利视频| 免费在线观看影片大全网站| 久9热在线精品视频| 丝袜在线中文字幕| 久9热在线精品视频| 悠悠久久av| 99香蕉大伊视频| 色哟哟哟哟哟哟| 欧美日韩视频精品一区| 动漫黄色视频在线观看| 男人的好看免费观看在线视频 | 亚洲自偷自拍图片 自拍| 国内毛片毛片毛片毛片毛片| 香蕉久久夜色| 性色av乱码一区二区三区2| 日韩免费高清中文字幕av| 国产有黄有色有爽视频| 中文字幕精品免费在线观看视频| 91av网站免费观看| 欧美人与性动交α欧美软件| 黄频高清免费视频| 久久精品亚洲熟妇少妇任你| 一夜夜www| 久久久久国产精品人妻aⅴ院| 高清黄色对白视频在线免费看| 亚洲国产精品合色在线| 交换朋友夫妻互换小说| 777久久人妻少妇嫩草av网站| 一个人观看的视频www高清免费观看 | 国产成人免费无遮挡视频| 亚洲精品国产精品久久久不卡| 美女福利国产在线| 亚洲九九香蕉| 一边摸一边抽搐一进一出视频| 国产精品久久视频播放| 在线观看www视频免费| 99在线视频只有这里精品首页| 三上悠亚av全集在线观看| 日本wwww免费看| 国产亚洲精品第一综合不卡|